March 02, 2023 at 9:55 pm

Tesla (TSLA) Stock Falls On Disappointing Investor Day

On Thursday, Tesla (TSLA) stocks experienced a decline after its investor day event, which failed to provide specifics about new products. However, CEO Elon Musk revealed his ambitious “Master Plan 3,” which calls for a complete transition to EVs and $10 trillion in spending to create a “sustainable energy future.” The event, held at Tesla’s… [Read More]
March 02, 2023 at 5:02 pm

SuperCom Secures $3.6M Finland Deal

SuperCom (Nasdaq: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, has launched a $3.6 million National Electronic Monitoring project in Finland. The company expects to generate recurring revenue from the project in the near future. Highlights The launch follows SuperCom’s successful competitive tender win which involved six providers, including… [Read More]
March 02, 2023 at 3:44 pm

Lipella Creates Oral Health Scientific Advisory Board

Lipella Pharmaceuticals (Nasdaq: LIPO), has appointed a five-member Scientific Advisory Board in oral health to focus on the development of LP-310 for the treatment of symptomatic oral lichen planus (OLP). The Board will also provide guidance on the design of the company’s Phase 2a multicenter dose escalation study of LP-310 for IND submission. Highlights Lipella’s… [Read More]
March 01, 2023 at 1:27 pm

A Pivotal Year Ahead for Quoin Pharmaceuticals

Company celebrates key milestones and charts path from clinical-stage to commercial. Since commencing trading on Nasdaq in October 2021, Quoin Pharmaceuticals ( Nasdaq: QNRX ) has rapidly established itself as a company with a clearly defined commercial approach to growth and an eye on multiple avenues for success. The company’s lead product candidate, QRX003, is… [Read More]
March 01, 2023 at 9:11 am

Orchard Therapeutics Secures Swedish Reimbursement Agreement for Libmeldy

Global gene therapy company, Orchard Therapeutics (Nasdaq: ORTX) has reached an agreement that will allow reimbursed access to Libmeldy for eligible metachromatic leukodystrophy (MLD) patients in Sweden. MLD is a rare and life-threatening inherited disease that causes damage to the nervous system. Infants diagnosed with MLD have a life expectancy of five years and adults… [Read More]
February 28, 2023 at 11:51 pm

Meta Joins The AI Chatbot Race to Rival Chat GPT

Mark Zuckerberg, the CEO of Meta, has announced that the tech giant is developing a new AI-powered chatbot, following in the footsteps of other tech companies inspired by the success of OpenAI’s ChatGPT. Zuckerberg made the announcement in a Facebook post on February 27, stating that the focus of the chatbot would be on developing… [Read More]
February 28, 2023 at 3:16 pm

4 Small-Cap Players Developing AI Technologies

4 Small-Cap Players Developing AI Technologies From chatbots to facial recognition, AI continues to garner headlines and global interest. More awareness also means that there are more options than just META (Nasdaq: META) and Microsoft (Nasdaq:MSFT). Check out the following microcap alternatives to keep on your radar: In the AI space, there are several microcap… [Read More]
February 28, 2023 at 2:14 pm

An Inside Look at Retail Earnings: Start Your Engines – Advance Auto Parts and Autozone (AAP, AZO)

Tuesday kicked off another round of big retail earnings with auto retailers Advance Auto Parts and Autozone announcing their results before today’s open. American automotive aftermarket parts provider, Advance Auto Parts Inc. (AAP) beat earnings and revenue consensus reporting Q4 EPS of $2.88 vs Factset $2.41 while Q4 revenues came in at $2.47B vs Factset… [Read More]